List of insiders holdings for Nuvalent, Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Shair Matthew Director | 2025-11-26 16:30:01 | 1,377,194 201,672 | 1,578,866 | Form 4 |
| 2 | Hack Andrew A. F. Director | 2024-12-13 16:30:06 | 2,499 1,447,267 | 1,449,766 | Form 4 |
| 3 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2021-08-03 20:01:28 | 897,671 0 | 897,671 | Form 4 |
| 4 | Jackson Robert Bowers Director | 2021-07-30 17:02:44 | 43,000 0 | 43,000 | Form 4 |
| 5 | Conley Emily Director | 2024-08-27 16:44:45 | 25,840 0 | 25,840 | Form 4 |
| 6 | Pearlberg Joseph Director | 2025-06-20 16:36:05 | 9,293 0 | 9,293 | Form 4 |
| 7 | Gilliland Dwight Gary Director | 2024-06-14 16:09:37 | 6,288 0 | 6,288 | Form 4 |
| 8 | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. Deerfield Mgmt HIF L.P. Deerfield Healthcare Innovations Fund L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by Deputization Director 10% Owner | 2026-07-17 15:27:57 | 0 0 | 0 | Form 13G |
| 9 | Meyers Michael L. Director | 2026-07-15 19:11:31 | 0 0 | 0 | Form 4 |
| 10 | Balcom Alexandra Chief Financial Officer | 2026-07-15 19:11:06 | 0 0 | 0 | Form 4 |
| 11 | Srivastava Sapna Director | 2026-07-15 19:07:32 | 0 0 | 0 | Form 4 |
| 12 | Oliger Christy J. Director | 2026-07-15 19:04:22 | 0 0 | 0 | Form 4 |
| 13 | Squarer Ron Director | 2026-07-15 19:03:13 | 0 0 | 0 | Form 4 |
| 14 | Turner Christopher Durant Chief Medical Officer | 2026-07-15 18:57:58 | 0 0 | 0 | Form 4 |
| 15 | Noci Darlene Chief Development Officer | 2026-07-15 18:57:46 | 0 0 | 0 | Form 4 |
| 16 | Lane Benjamin See Remarks | 2026-07-15 18:50:51 | 0 0 | 0 | Form 4 |
| 17 | Pelish Henry E. Chief Scientific Officer | 2026-07-15 18:47:11 | 0 0 | 0 | Form 4 |
| 18 | Porter James Richard President and CEO | 2026-07-15 18:43:01 | 0 0 | 0 | Form 4 |
| 19 | Miller Deborah Ann Chief Legal Officer | 2026-07-15 18:42:26 | 0 0 | 0 | Form 4 |
| 20 | Protopapas Anna Director | 2026-07-15 18:36:35 | 0 0 | 0 | Form 4 |
| 21 | Bogle Grant C. Director | 2026-07-15 18:35:58 | 0 0 | 0 | Form 4 |
| 22 | Wheeler Cameron Director | 2026-07-15 18:35:54 | 0 0 | 0 | Form 4 |